Please login to the form below

Not currently logged in
Email:
Password:

German court blocks hearing aid manufacturer takeover bid

Swiss hearing aid manufacturer Sonova may give up on its bid for a Danish competitor after a German court ruled that it would not dismiss a regulator's decision to block the deal

Swiss hearing aid manufacturer Sonova may give up on its bid for a Danish competitor after a German court ruled that it would not dismiss a regulator's decision to block the deal.

The Duesseldorf regional court refused to issue an injunction against a decision by Germany's anti-cartel agency blocking Sonova's CHF 3.3bn (USD 2.8bn) bid for Denmark-headquartered GN Store Nord ReSound Group.

The German Federal Cartel Office previously blocked the deal in April 2007 saying it was concerned it would lead to a monopoly in the German market.

GN said the decision was a departure from previous case law and, in a statement, said that the ruling would effectively give the German Federal Cartel Office unfettered power to prohibit mergers without effective judicial review as transactions could not be kept in limbo for years awaiting the outcome of main proceedings.

GN added that if the deal was abandoned, it would look at all options including, but not limited, to a listing of GN Store Nord into two separate listed entities.

8th August 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics